RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. Norgine Ventures
N

Norgine Ventures portfolio

Norgine Ventures has 2 portfolio companies on record at Recent Funding.

Type: Investor.
Portfolio on Recent Funding: 2.
Deals, last 12 months: 0.
Rounds led: 1 of 1.
Capital in their rounds: $100M.
Latest deal: Impress · Jul 11, 2022.
About this page

Its most recent investment on record is Impress's $100M Series B+ round in July 2022, which it led, alongside LBO France, UNIQA Ventures GmbH, Nickleby Capital and 3 others. By category, its portfolio leans toward Health and bio (2).

What Norgine Ventures invests in

How Norgine Ventures invests

StageDealsCapital in rounds
Series B+ 1 100%$100M

Norgine Ventures portfolio companies

CompanyRound with Norgine VenturesTotal raisedLatest raise
IImpress
Health and bio
Series B+ · $100M · lead$155.89MJul 11, 2022
Series B+
IInovus Medical
Health and bio
backer$20MSep 29, 2026
round

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Share is of the 1 round on Recent Funding that name Norgine Ventures. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists Norgine Ventures, which is a subset of its real portfolio. API: /api/v1/investors/norgine-ventures (get a free API key). More: the most active VC firms and new venture capital funds.